Global Drugs for Schistosomiasis Market Research Report 2015-2025

HEY3761342
77 Pages
March 2020
Healthcare

Download Sample Get Discount

Summary

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

The global Drugs for Schistosomiasis market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Praziquantel

Oxamniquine

Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Merck

Shin Poong

Bayer

EIPICO

Chandra Bhagat Pharma

Taj Pharmaceuticals

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

S. haematobium

S. mansoni

S. japonicum

S. mekongi

S. intercalatum

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Drugs for Schistosomiasis Picture

1.1.2 Specifications

Table Product Specifications of Drugs for Schistosomiasis

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Drugs for Schistosomiasis

Table Global Drugs for Schistosomiasis Market by Type, 2011-2022 (USD Million)

1.2.1.1 Praziquantel

Table Praziquantel Overview

1.2.1.2 Oxamniquine

Table Oxamniquine Overview

1.2.1.3 Others

Table Others Overview

1.2.2 by Application

Table Application Segment of Drugs for Schistosomiasis

Table Global Drugs for Schistosomiasis Market by Application, 2011-2022 (USD Million)

1.2.2.1 S. haematobium

Table S. haematobium Overview

1.2.2.2 S. mansoni

Table S. mansoni Overview

1.2.2.3 S. japonicum

Table S. japonicum Overview

1.2.2.4 S. mekongi

Table S. mekongi Overview

1.2.2.5 S. intercalatum

Table S. intercalatum Overview

1.2.3 by Regions

Table Global Drugs for Schistosomiasis Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Drugs for Schistosomiasis

2.2 Upstream

Table Cost of Drugs for Schistosomiasis

Figure Manufacturing Process of Drugs for Schistosomiasis

2.3 Market

2.3.1 SWOT

Figure SWOT of Drugs for Schistosomiasis

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Drugs for Schistosomiasis

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Drugs for Schistosomiasis

3.4 Market Entry

Table Market Entry of Drugs for Schistosomiasis

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Praziquantel Market, 2013-2018

Figure Praziquantel Market Size and Growth, 2015-2019 (USD Million)

Figure Praziquantel Market Size and Growth, 2015-2019 (in Volume)

Table Praziquantel CAGR by Revenue and Volume, 2015-2019

4.1.2 Oxamniquine Market, 2013-2018

Figure Oxamniquine Market Size and Growth, 2015-2019 (USD Million)

Figure Oxamniquine Market Size and Growth, 2015-2019 (in Volume)

Table Oxamniquine CAGR by Revenue and Volume, 2015-2019

4.1.3 Others Market, 2013-2018

Figure Others Market Size and Growth, 2015-2019 (USD Million)

Figure Others Market Size and Growth, 2015-2019 (in Volume)

Table Others CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 Praziquantel Market Forecast, 2020-2025

Figure Praziquantel Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Praziquantel Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Praziquantel CAGR by Revenue and Volume, 2012-2024

4.2.2 Oxamniquine Market Forecast, 2020-2025

Figure Oxamniquine Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Oxamniquine Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Oxamniquine CAGR by Revenue and Volume, 2012-2024

4.2.3 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 S. haematobium Market, 2013-2018

Figure S. haematobium Market Size and Growth, 2015-2019 (USD Million)